Largest study to date of lebrikizumab supports its use for treatment of atopic dermatitis

Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to a paper published in the New England Journal of Medicine.

Leave A Comment

Your email address will not be published. Required fields are marked *